Genetic Profiling and Comorbidities of Zika Infection

Journal of Infectious Diseases

Volumn 216, Issue 6, 2017, Pages 703-712

  Moni, Mohammad Ali ^a   Lio, Pietro ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Co infections; Comorbidities; Diseasome; Genetic profiling.; Zika Infection

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR MAFB;

ARTICLE; ATF5 GENE; BAMB1 GENE; CHIKUNGUNYA; COMORBIDITY; CONTROLLED STUDY; DENGUE; FLAVIVIRUS INFECTION; GENETIC ASSOCIATION; GUILLAIN BARRE SYNDROME; JAPANESE ENCEPHALITIS VIRUS; MAFB GENE; MICROARRAY ANALYSIS; NAMPT GENE; NONHUMAN; PHYLOGENETIC TREE; PMALP1 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA SEQUENCE; SELENBP1 GENE; TNFAIP3 GENE; VIRUS GENE; WEST NILE FEVER; YELLOW FEVER; ZIKA FEVER; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; ISOLATION AND PURIFICATION; PHYLOGENY; RNA VIRUS; RNA VIRUS INFECTIONS; SEQUENCE ANALYSIS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

COMORBIDITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HOST-PATHOGEN INTERACTIONS; HUMANS; PHYLOGENY; RNA VIRUS INFECTIONS; RNA VIRUSES; SEQUENCE ANALYSIS, RNA; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85030609879     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix327     Document Type: Article

References (28)

1. Moni MA, Liò P. Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies. BMC Bioinformatics 2014; 15:1.
2. Navratil V, de Chassey B, Combe CR, Lotteau V. When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases. BMC Syst Biol 2011; 5:1.
3. Segura-Cabrera A, García-Pérez CA, Guo X, Rodríguez-Pérez MA. A viral-human interactome based on structural motif-domain interactions captures the human infectome. PLoS One 2013; 8:e71526.
4. Yacoub S, Wertheim H, Simmons CP, Screaton G, Wills B. Cardiovascular manifestations of the emerging dengue pandemic. Nat Rev Cardiol 2014; 11:335.
5. Garcez PP, Nascimento JM, de Vasconcelos JM, et al. Zika virus disrupts molecular fingerprinting of human neurospheres. Sci Rep 2017; 7:40780.
6. Hamel R, Liégeois F, Wichit S, et al. Zika virus: epidemiology, clinical features and host-virus interactions. Microbes Infect 2016; 18:441-9.
7. Driggers RW, Ho C-Y, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016; 374:2142-51.
8. Fauci AS, Morens DM. Zika virus in the Americas-yet another arbovirus threat. N Engl J Med 2016; 374:601-4.
9. Ioos S, Mallet H-P, Goffart IL, Gauthier V, Cardoso T, Herida M. Current Zika virus epidemiology and recent epidemics. Med Mal Infect 2014; 44:302-7.
10. Tang H, Hammack C, Ogden SC, et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 2016; 18:587-90.
11. Cao-Lormeau V-M, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016; 387:1531-9.
12. Tilak R, Ray S, Tilak VW, Mukherji S. Dengue, chikungunya⋯ and the missing entity-Zika fever: a new emerging threat. Med J Armed Forces India 2016; 72:157-63.
13. Narayanan R. Zika virus therapeutics: drug targets and repurposing medicine from the human genome. MOJ Proteomics & Bioinformatics 2016; 3:00084.
14. Marcin K, Nakaya HI, Onlamoon N, et al. Dengue virus infection induces expansion of a CD14 (+) CD16 (+) monocyte population that stimulates plasmablast differentiation. Cell Host & Microbe 2014; 16:115-27.
15. Karlas A, Berre S, Couderc T, et al. A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs. Nat Commun 2016; 7:11320.
16. Qian F, Goel G, Meng H, et al. Systems immunology reveals markers of susceptibility to West Nile virus infection. Clin Vaccine Immunol 2015; 22:6-16.
17. Gaucher D, Therrien R, Kettaf N, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008; 205:3119-31.
18. Chang K-H, Chuang T-J, Lyu R-K, et al. Identification of gene networks and pathways associated with Guillain-Barre syndrome. PLoS One 2012; 7:e29506.
19. Amberger J, Bocchini C, Hamosh A. A new face and new challenges for Online Mendelian Inheritance in Man (OMIM). Hum Mutat 2011; 32:564-7.
20. Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L. The human disease network. Proc Natl Acad Sci USA 2007; 104:8685-90.
21. Moni MA, Liò P. comoR: a software for disease comorbidity risk assessment. J Clin Bioinforma 2014; 4:1.
22. Moni MA, Liò P. How to build personalized multi-omics comorbidity profiles. Front Cell Dev Biol 2015; 3:28.
23. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and clustal X version 2.0. Bioinformatics 2007; 23:2947-8.
24. Kumar S, Nei M, Dudley J, Tamura K. Mega: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 2008; 9:299-306.
25. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 2017; 45:D353-61.
26. Smith SA, Beaulieu JM, Donoghue MJ. Mega-phylogeny approach for comparative biology: an alternative to supertree and supermatrix approaches. BMC Evol Biol 2009; 9:37.
27. Rolfe AJ, Bosco DB, Wang J, Nowakowski RS, Fan J, Ren Y. Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells. Cell Biosci 2016; 6:42.
28. Moni MA, Liò P. Infectome, diseasome and comorbidities of Zika infection. IJID 2016; 53:14.